65.83MMarket Cap-2523P/E (TTM)
1.820High1.585Low413.91KVolume1.660Open1.630Pre Close684.29KTurnover1.31%Turnover RatioLossP/E (Static)40.14MShares2.65052wk High9.53P/B51.80MFloat Cap1.08052wk Low--Dividend TTM31.59MShs Float19.500Historical High--Div YieldTTM14.41%Amplitude0.840Historical Low1.653Avg Price1Lot Size
Modular Medical Stock Forum
Modular Medical Announces Results from a Successful GLP-1 Proof of Concept Study
Modular Medical (NASDAQ:MODD) announced successful results from its pre-clinical GLP-1 proof of concept study. The study demonstrated enhanced weight loss and blood glucose control using a pump-delivered rapid-acting GLP-1 with both basal and bolus dosing. The highest basal-bolus dose achieved 17.1% weight loss at 28 days, compared to 13.7% with basal alone. All dosing variations outpe...
Accesswire· 5 mins ago
ACCESSWIRE 11-Sep-2024 8:02 AM
-Proof of Concept Study in Rapid Acting GLP-1 to commence in October 2024 with data expected in November 2024
-Pre-clinical study to explore use of MODD1 pump as a personalized delivery system for people who discontinue long-acting GLP-1 formulations
-CEO to discuss further details of the program in Tribe Pu...
Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), an insulin delivery system technology company preparing to launch a market expansion product with a more accessible, easier to prescribe, and easier to pay for and live wi...
No comment yet